| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4062878
Max Phase: Preclinical
Molecular Formula: C16H19N3O3S
Molecular Weight: 333.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1=CN(c2ccc(S(N)(=O)=O)cc2)C(C2C=CN(C)C=C2)O1
Standard InChI: InChI=1S/C16H19N3O3S/c1-12-11-19(14-3-5-15(6-4-14)23(17,20)21)16(22-12)13-7-9-18(2)10-8-13/h3-11,13,16H,1-2H3,(H2,17,20,21)
Standard InChI Key: BCJHOOXOLNBHDG-UHFFFAOYSA-N
Associated Targets(non-human)
Cyclooxygenase-1 1373 Activities
Cyclooxygenase-2 182 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 333.41 | Molecular Weight (Monoisotopic): 333.1147 | AlogP: 1.95 | #Rotatable Bonds: 3 |
| Polar Surface Area: 75.87 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.75 | CX Basic pKa: 7.60 | CX LogP: 1.34 | CX LogD: 0.93 |
| Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.91 | Np Likeness Score: -0.35 |
References
| 1. Zhou S, Yang S, Huang G.. (2017) Design, synthesis and bioactivities of Celecoxib analogues or derivatives., 25 (17): [PMID:28757100] [10.1016/j.bmc.2017.07.038] |
Source
Source(1):